<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 11 Jul 2026 16:08:11 -0400--><rss version="2.0">
    <channel>
        <title>IceCure Medical Ltd. (ICCM) Press Releases</title>
        <link>https://ir.icecure-medical.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_54f40390b69697dace3343a57e47c1a7/icecuremedical/files/theme/images/logo-sm.png</url>
                <title>IceCure Medical Ltd. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/228/icecure-highlights-expanding-commercial-adoption-of-prosense-cryoablation-in-brazil-following-fda-clearance-for-breast-cancer</link>
                <pubDate>Mon, 06 Jul 26 08:11:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/228/icecure-highlights-expanding-commercial-adoption-of-prosense-cryoablation-in-brazil-following-fda-clearance-for-breast-cancer</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/227/icecure-regains-compliance-with-nasdaq-minimum-bid-price-requirement</link>
                <pubDate>Thu, 25 Jun 26 08:12:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/227/icecure-regains-compliance-with-nasdaq-minimum-bid-price-requirement</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/226/icecure-highlights-new-peer-reviewed-journal-article-in-leading-surgery-journal-demonstrating-cryoablations-advantages-over-radiofrequency-ablation-for-early-stage-breast-cancer</link>
                <pubDate>Tue, 23 Jun 26 08:10:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/226/icecure-highlights-new-peer-reviewed-journal-article-in-leading-surgery-journal-demonstrating-cryoablations-advantages-over-radiofrequency-ablation-for-early-stage-breast-cancer</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/225/icecure-announces-pricing-of-5-5-million-private-placement-priced-at-a-premium-to-the-market-price-with-a-single-healthcare-focused-institutional-investor</link>
                <pubDate>Wed, 17 Jun 26 13:14:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/225/icecure-announces-pricing-of-5-5-million-private-placement-priced-at-a-premium-to-the-market-price-with-a-single-healthcare-focused-institutional-investor</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/224/icecure-reports-70-growth-in-active-u-s-commercial-install-base-for-breast-cancer-cryoablation-following-fda-clearance</link>
                <pubDate>Wed, 17 Jun 26 08:25:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/224/icecure-reports-70-growth-in-active-u-s-commercial-install-base-for-breast-cancer-cryoablation-following-fda-clearance</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/223/icecure-medical-announces-1-for-30-reverse-share-split-to-support-nasdaq-compliance</link>
                <pubDate>Tue, 02 Jun 26 08:30:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/223/icecure-medical-announces-1-for-30-reverse-share-split-to-support-nasdaq-compliance</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/222/icecures-prosense-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-data-presented-at-ecio-2026-and-first-ever-breast-cryoablation-master-class-overbooked</link>
                <pubDate>Tue, 19 May 26 08:30:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/222/icecures-prosense-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-data-presented-at-ecio-2026-and-first-ever-breast-cryoablation-master-class-overbooked</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/221/icecure-granted-180-day-extension-by-nasdaq-to-regain-compliance-with-minimum-bid-requirement</link>
                <pubDate>Wed, 13 May 26 16:30:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/221/icecure-granted-180-day-extension-by-nasdaq-to-regain-compliance-with-minimum-bid-requirement</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/220/icecure-reports-first-quarter-2026-financial-results-prosense-sales-increase-substantially-in-the-u-s-and-north-america</link>
                <pubDate>Tue, 12 May 26 08:30:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/220/icecure-reports-first-quarter-2026-financial-results-prosense-sales-increase-substantially-in-the-u-s-and-north-america</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/219/icecure-medical-to-report-first-quarter-2026-financial-and-operating-results-on-may-12-2026</link>
                <pubDate>Wed, 06 May 26 08:30:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/219/icecure-medical-to-report-first-quarter-2026-financial-and-operating-results-on-may-12-2026</guid>
                                                                            </item>
            </channel>
</rss>